Page last updated: 2024-10-29

indapamide and Brain Vascular Disorders

indapamide has been researched along with Brain Vascular Disorders in 13 studies

Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.

Research Excerpts

ExcerptRelevanceReference
"The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) showed that blood pressure lowering reduced stroke risk in patients with a history of cerebrovascular events."9.11Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. ( Anderson, C; Bousser, MG; Chalmers, J; Chapman, N; Colman, S; Davis, S; Donnan, G; Huxley, R; MacMahon, S; Neal, B; Warlow, C; Woodward, M, 2004)
"The primary aim of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) is to determine the effects of a long-term angiotensin converting enzyme (ACE)-inhibitor-based blood-pressure-lowering regimen on the risk of stroke among patients with a history of stroke or transient ischaemic attack (TIA)."9.09PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee. ( , 1999)
"The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) showed that blood pressure lowering reduced stroke risk in patients with a history of cerebrovascular events."5.11Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. ( Anderson, C; Bousser, MG; Chalmers, J; Chapman, N; Colman, S; Davis, S; Donnan, G; Huxley, R; MacMahon, S; Neal, B; Warlow, C; Woodward, M, 2004)
"Among individuals with cerebrovascular disease, a perindopril-based blood pressure-lowering regimen not only reduced the risk of stroke and major vascular events but also substantially reduced the risks of associated long-term disability and dependency."5.10Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial. ( Anderson, C; Chalmers, J; Chapman, N; Davis, S; Fransen, M; MacMahon, S; Neal, B; Sega, R; Terent, A; Tzourio, C; Woodward, M, 2003)
"The primary aim of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) is to determine the effects of a long-term angiotensin converting enzyme (ACE)-inhibitor-based blood-pressure-lowering regimen on the risk of stroke among patients with a history of stroke or transient ischaemic attack (TIA)."5.09PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee. ( , 1999)
"5 mg SR formulation of indapamide has an improved antihypertensive efficacy : safety ratio, which is in accordance with international recommendations for the use of low-dose antihypertensive drugs and diuretics in first-line therapy of hypertension."5.08Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group. ( Ambrosioni, E; de Cordoüe, A; Degaute, JP; Guez, D; MacMahon, M; Malin, PL; Pujol, DR; Safar, M, 1998)
"Hyperlipidemia is a widely acknowledged side effect of thiazide diuretic therapy, but it is often dismissed as a short-term effect of high-dose therapy."2.40Hyperlipidemia of diuretic therapy. ( Ames, R, 1998)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (69.23)18.2507
2000's3 (23.08)29.6817
2010's1 (7.69)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afanas'ev, IuI1
Storozhenko, SIu1
Grigorova, SIu1
Tzourio, C2
Anderson, C3
Chapman, N3
Woodward, M3
Neal, B3
MacMahon, S3
Chalmers, J3
Fransen, M1
Davis, S2
Sega, R1
Terent, A1
Huxley, R1
Bousser, MG1
Colman, S1
Donnan, G1
Warlow, C1
Contard, F1
Sabri, A1
Glukhova, M1
Sartore, S1
Marotte, F1
Pomies, JP1
Schiavi, P1
Guez, D2
Samuel, JL1
Rappaport, L1
Levy, BI1
Poitevin, P1
Duriez, M1
Guez, DC1
Schiavi, PD1
Safar, ME1
Biagini, G2
Zoli, M1
Torri, C1
Boschi, S1
Vantaggiato, G1
Ballestri, M1
Baraldi, A1
Agnati, LF1
Ames, R1
Razzetti, R1
Bongrani, S1
Oberto, G1
Ferrari, R1
Ambrosioni, E1
Safar, M1
Degaute, JP1
Malin, PL1
MacMahon, M1
Pujol, DR1
de Cordoüe, A1

Reviews

1 review available for indapamide and Brain Vascular Disorders

ArticleYear
Hyperlipidemia of diuretic therapy.
    Archives des maladies du coeur et des vaisseaux, 1998, Volume: 91 Suppl

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cere

1998

Trials

7 trials available for indapamide and Brain Vascular Disorders

ArticleYear
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
    Archives of internal medicine, 2003, May-12, Volume: 163, Issue:9

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cerebrovasc

2003
Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.
    Stroke, 2003, Volume: 34, Issue:10

    Topics: Activities of Daily Living; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood

2003
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
    Stroke, 2004, Volume: 35, Issue:1

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Brain Ische

2004
Post-stroke antihypertensive treatment study. A preliminary result.
    Chinese medical journal, 1995, Volume: 108, Issue:9

    Topics: Aged; Antihypertensive Agents; Cerebrovascular Disorders; China; Double-Blind Method; Female; Humans

1995
PROGRESS: Perindopril pROtection aGainst REcurrent Stroke Study: status in March 1997. PROGRESS Management Committee.
    Journal of human hypertension, 1998, Volume: 12, Issue:9

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cerebrovascular Disorders; Diuretics; Double-Blind M

1998
Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.
    Journal of hypertension, 1998, Volume: 16, Issue:11

    Topics: Adult; Aged; Angina Pectoris; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; De

1998
PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
    Journal of hypertension, 1999, Volume: 17, Issue:11

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cerebrovascular Disorders; Diuretics

1999

Other Studies

5 other studies available for indapamide and Brain Vascular Disorders

ArticleYear
[Potentialities of medicinal correction of cerebrovascular disturbances in patients with arterial hypertension].
    Klinicheskaia meditsina, 2012, Volume: 90, Issue:6

    Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Cerebrovascular Disorders; Drug Therapy, Combinatio

2012
Arterial smooth muscle cell phenotype in stroke-prone spontaneously hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 1993, Volume: 22, Issue:5

    Topics: Actins; Animals; Aorta, Thoracic; Cerebral Cortex; Cerebrovascular Disorders; Fibronectins; Hydrochl

1993
Sodium, survival, and the mechanical properties of the carotid artery in stroke-prone hypertensive rats.
    Journal of hypertension, 1997, Volume: 15, Issue:3

    Topics: Animals; Blood Pressure; Body Weight; Carotid Artery, Common; Cerebrovascular Disorders; Collagen; D

1997
Protective effects of delapril, indapamide and their combination chronically administered to stroke-prone spontaneously hypertensive rats fed a high-sodium diet.
    Clinical science (London, England : 1979), 1997, Volume: 93, Issue:5

    Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bl

1997
Protective effects of delapril, indapamide and their combination on stroke occurrence and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats.
    Arzneimittel-Forschung, 1998, Volume: 48, Issue:11

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cerebrovascular Disorders; Diuretics

1998